Molecular Diagnostics

In Other News

• Machine Learning Approach Expands Epigenetic Testing for Prenatal Genetic Disorders

• New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

• Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

• Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

• Liquid Biopsy Combines Multiple Signals for Cancer Detection in a Single Analysis

• Newborn Screening Program Adds Spinal Muscular Atrophy Testing Across England

• Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

• Blood Test Could Help Fast-Track Lymphoma Diagnosis in Resource-Limited Settings

• Liquid Biopsy Assay Enriches Tumor DNA for Early Detection and Monitoring

• Point-of-Care Multiplex PCR Test Submitted to FDA for Flu A/B and RSV Detection

• New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

• Global Testing Service Advances Leukemia MRD Monitoring

• Ultrasensitive MRD Assay Gains Medicare Coverage for Immunotherapy and Breast Cancer Monitoring

• Single Liquid Biopsy Predicts Early Immunotherapy Benefit in Advanced Lung Cancer

• Machine Learning Tool Improves Prediction of Liver Cancer Recurrence

• AI-Powered Liquid Biopsy Detects Liver Cancer Across Diverse Populations

• Circular RNAs Enable Noninvasive Cancer Detection and Risk Assessment

• Polygenic Risk Score Test Estimates Inherited Coronary Artery Disease Risk

• AI Tool Improves Long-Read Detection of Cancer Mutations

• FDA Clears Molecular Test for Bacterial Vaginosis and Candida Vaginitis

• Cepheid Presents Third-Generation GeneXpert System at ADLM 2026

• Blood Protein Panel Predicts Timing of ALS Symptom Onset

• Blood Gene Expression Fluctuates More Than Expected Over Time